MedTrace Logo

Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia

NCT02003612 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2373

Last updated 2022-11-07

No results posted yet for this study

Summary

A retrospective analysis of historical data looking at hematological remission and survival in adult relapsed / refractory B-precursor acute lymphoblastic leukemia patients.

Conditions

Interventions

OTHER

Not applicable - observational study

No intervention exists as this is a retrospective observational study

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2014-01-10
Completion
2014-04-28

Countries

  • United States
  • Czechia
  • France
  • Germany
  • Italy
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02003612 on ClinicalTrials.gov